Clinical Trial

Beta-lactam Plus Levofloxacin to Enhance Therapy in Streptococcal Septicemia

Study acronym: BLESS
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
A double-blind randomized controlled trial comparing beta-lactam plus levofloxacin versus beta-lactam monotherapy for the treatment of Streptococcal bacteremia
Trial Details
NCT Number NCT07240077
Lead Sponsor Mahidol University
Conditions Bacteremia, Streptococcus Infection
Enrollment 165 participants
Start Date 2026-01-01
Primary Completion 2027-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-11-20